Authors: Odin, L Favrot, M Poujol, D Michot, JP Moingeon, P Tartaglia, J Puisieux, I

Citation: L. Odin et al., Canarypox virus expressing wild type p53 for gene therapy in murine tumorsmutated in p53, CANC GENE T, 8(2), 2001, pp. 87-98

Authors: Jouanneau, E Alberti, L Nejjari, M Treilleux, I Vilgrain, I Duc, A Combaret, V Favrot, M Leboulch, P Bachelot, T

Citation: E. Jouanneau et al., Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model, J NEURO-ONC, 51(1), 2001, pp. 11-18

Authors: Coll, JL Chollet, P Brambilla, E Desplanques, D Behr, JP Favrot, M

Citation: Jl. Coll et al., In vivo delivery to tumors of DNA complexed with linear polyethylenimine, HUM GENE TH, 10(10), 1999, pp. 1659-1666

Authors: Bour, H Puisieux, I Even, J Kourilsky, P Favrot, M Musette, P Nicolas, JF

Citation: H. Bour et al., T-cell repertoire analysis in chronic plaque psoriasis suggests an antigen-specific immune response, HUMAN IMMUN, 60(8), 1999, pp. 665-676

Authors: Gilly, FN Beaujard, A Bienvenu, J Lenoir, VT Glehen, O Thouvenot, D Malcus, C Favrot, M Dumontet, C Lomhard-Bohas, C Garbit, F Gueugniaud, PY Vignal, J Aymard, M Moulin, FT Roos, M Pavirani, A Courtney, M

Citation: Fn. Gilly et al., Gene therapy with AdV-IL-2 in unresectable digestive cancer: Phase I-II study, intermediate report, HEP-GASTRO, 46, 1999, pp. 1268-1273